Objective To investigate the association of the expression of the NK cell-activating receptor NKG2 D,its ligand major histocompatibility complex class I chain-related gene A( MICA),and related cytokines [interferon-γ( IFN-γ),interleukin-10( IL-10),and interleukin-15( IL-15) ] with intrahepatic inflammation in primary biliary cholangitis( PBC). Methods Liver biopsy specimens were collected from 30 patients with PBC( PBC group),15 patients with chronic hepatitis B( CHB group),and 10 patients with nonalcoholic fatty liver disease( NAFLD group),who were hospitalized in The Second Affiliated Hospital of Kunming Medical University from August 2014 to June 2015. The degree of liver inflammation( G) and fibrosis degree( S) of the liver specimens were determined,and immunohistochemistry was used to measure the expression of NKG2 D,MICA,IFN-γ,IL-10,and IL-15 in liver tissue( the scores were determined based on the number of cells stained and the degree of staining to evaluate the expression of each marker). A one-way analysis of variance was used for comparison of continuous data between multiple groups,and the t-test was used for comparison between two groups; a Spearman correlation analysis was used to investigate correlation. Results In the PBC group,the expression of NKG2 D increased with the degree of inflammation,and the patients with G3-4 inflammation had significantly higher expression than those with G1-2 inflammation( G1 vs G2 vs G3 vs G4: 1. 4 ± 0. 05 vs 1. 56 ± 0. 05 vs 1. 86 ± 0. 11 vs 2. 60 ± 0. 17,F = 150. 8,P < 0. 05); the expression of NKG2 D decreased with fibrosis degree( S3 vs S4: 2. 30 ± 0. 17 vs 1. 56 ± 0. 05,t =-1. 52,P < 0. 05). In the PBC group,there was no significant difference in MICA between G3 and G4( 0. 11 ± 0. 01 vs 0. 20 ± 0. 03,t =-2. 20,P > 0. 05) and between S3 and S4( 0. 12 ±0. 02 vs 0. 18 ± 0. 03,t =-2. 64,P > 0. 05). In the PBC group,there was a significant difference in the expression of IL-15 between the patients with different degrees of inflammation( G1 vs G2 vs G3 vs G4: 0. 70 ± 0. 10 vs 1. 50 ± 0. 10 vs 1. 93 ± 0. 11 vs 2. 60 ± 0. 17,F =251. 3,P < 0. 05),while there was no significant difference between the patients with different fibrosis degrees( S3 vs S4: 2. 00 ± 0. 05 vs2. 40 ± 0. 30,t =-1. 62,P > 0. 05). In the CHB group,there was a significant difference in the expression of IL-15 between the patients with different degrees of inflammation( G1 vs G2 vs G3: 0. 73 ± 0. 15 vs 1. 96 ± 0. 15 vs 2. 50 ± 0. 17,F = 150,P < 0. 05) and between the patients with different fibrosis degrees( S1 vs S2 vs S3: 0. 70 ± 0. 10 vs 21. 96 ± 0. 15 vs 2. 50 ± 0. 17,F = 158. 7,P < 0. 05). In the PBC group,the expression of IL-10 was only observed in the patients with G1 inflammation( 0. 16 ± 0. 01),and in the CHB group,the expression of IL-10 was observed in the patients with G1 and G2 inflammation,with no significant difference( G1 vs G2: 0. 19 ± 0. 01 vs0. 13 ± 0. 01,t =-1. 522,P > 0. 05). In the patients with PBC,the expression of IL-15 in liver tissue was positively correlated with the levels of alkaline phosphatase( ALP) and gamma-glutamyl transpeptidase( GGT)( r = 0. 241 and 0. 407,P = 0. 014 and 0. 045).Conclusion The NK cell-activating receptor NKG2 D affects the degree of intrahepatic inflammation in PBC,and the NKG2 D ligand MICA is expressed in the advanced stage of PBC and can downregulate NKG2 D. The expression of IL-15 increases with the degree of inflammation in PBC and is positively correlated with the levels of ALP and GGT,suggesting that the activation of NK cells and abnormal secretion of cytokines are involved in the development and progression of PBC and IL-15 may be used as an auxiliary index for the diagnosis of PBC.
[1] CHEUNG KS,SETO WK,FUNG J,et al. Epidemiology and natural history of primary biliary cholangitis in the Chinese:A territory-based study in Hong Kong between 2000 and 2015[J]. Clin Transl Gastroenterol,2017,8(8):e116.
|
[2] SHIMODA S,HISAMOTO S,HARADA K,et al. Natural killer cells regulate T cell immune responses in primary biliarycirrhosis[J]. Hepatology,2016,62(6):1817-1827.
|
[3] GENG X,LI M,CUI B,et al. CD4+CD25+Foxp3+regulatory T cells suppress NKG2D-mediated NK cell cytotoxicity in peripheral blood[J]. Medicine(Baltimore),2019,98(22):e15722.
|
[4] VULETIC'A,JOVANIC'I,JURISIC'V,et al. IL-2 And IL-15 Induced NKG2D,CD158a and CD158b expression on T,NKT-like and NK cell lymphocyte subsets from regional lymph nodes of melanoma patients[J]. Pathol Oncol Res,2020,26(1):223-231.
|
[5] LINDOR KD,GERSHWIN ME,POUPON R,et al. Primary biliary cirrhosis[J]. Hepatology,2009,50(1):291-308.
|
[6] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1958.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年版)[J].临床肝胆病杂志,2015,31(12):1941-1958.
|
[7] The Chinese National Work-shop on Fatty Liver and Alcoholic Liver Disease forthe Chinese Liver Disease Association. Guidelines for m anagem entofnonalcoholic fatty liver disease:An updated and revised edition[J]. J Clin Hepatol,2010,26(2):120-124.(in Chinese)中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志,2010,26(2):120-124.
|
[8] CHANG CH,CHEN YC,ZHANG W,et al. Innate immunity drives the initiation of a murine model of primary biliary cirrhosis[J]. PLo S One,2015,10(3):e0121320.
|
[9] SHIMODA S,HISAMOTO S,HARADA K,et al. Natural killer cells regulate T cell immune responses in primary biliary cirrhosis[J]. Hepatology,2015,62(6):1817-1827.
|
[10] TANG YM,BAO WM,XIA HX,et al. Study on natural killer cells and related cytokines in liver and peripheral blood of patients with primary biliary cirrhosis[J]. Chin J Dig,2009,29(8):560-561.(in Chinese)唐映梅,包维民,夏华向,等.原发性胆汁性肝硬化患者肝脏和外周血自然杀伤细胞及其相关细胞因子的研究[J].中华消化杂志,2009,29(8):560-561.
|
[11] TANG Y,BAO WM,YANG JH,et al. Expression of NKG2D/MIC in natural killer cell subsets of patients with primary biliary cirrhosis[J]. Chin J Hepatol,2015,23(8):574-579.(in Chinese)唐映梅,包维民,杨晋辉,等.原发性胆汁性肝硬化患者外周血自然杀伤细胞亚群及NKG2D/MIC表达研究[J].中华肝脏病杂志,2015,23(8):574-579.
|
[12] ALLEZ M,TIENG V,NAKAZAWA A,et al. CD4+NKG2D+T cells in Crohn’s disease mediate inflammatory and cytotoxic responses through MICA interactions[J]. Gastroenterology,2007,132(7):2346-2358.
|
[13] WANG XX,PAN XB,HAN JC,et al. HBs Ag stimulates NKG2D receptor expression on natural kil er cells and inhibits hepatitis C virus replication[J]. Hepatobiliary Pancreat Dis Int,2018,17(3):233-240.
|
[14] LI Y,WANG JJ,GAO S,et al. Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B[J]. PLo S One,2014,9(2):e86927.
|
[15] BAILEY CP,BUDAK-ALPDOGAN T,SAUTER CT,et al. New interleukin-15 superagonist(IL-15SA)significantly enhances graft-versus-tumor activity[J]. Oncotarget,2017,8(27):44366-44378.
|
[16] LI CD,CHEN XL,DUAN ZJ,et al. Determination of proportions of T cell subsets and levels of interleukin-15 and interleukin-16 in peripheral blood of patients with chronic hepatitis B virus infection and correlation between them[J]. J Clin Hepatol,2015,31(11):1857-1861.(in Chinese)李彩东,陈锡莲,段正军,等.慢性HBV感染者外周血T淋巴细胞亚群的变化及其与白细胞介素15、白细胞介素16的相关性分析[J].临床肝胆病杂志,2015,31(11):1857-1861.
|
[17] CHEN T,ZHU L,SHI A,et al. Functional restoration of CD56bright NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B[J]. Hepatol Int,2017,11(5):419-428.
|
[18] PARK JY,LEE SH,YOON SR,et al. IL-15-induced IL-10increases the cytolytic activity of human natural killer cells[J].Mol Cells,2011,32(3):265-272.
|
[19] HSUEH YH,CHEN HW,SYU BJ,et al. Endogenous IL-10maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis[J]. J Autoimmun,2018,95:159-170.
|
[20] CHUANG YH,LIAN ZX,TSUNEYAMA K,et al. Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis[J]. J Autoimmun,2006,26(4):232-240.
|
[21] ABULIZI A,SHAO Y,AJI T,et al. Echinococcus multilocularis inoculation induces NK cell functional decrease through high expression of NKG2A in C57BL/6 mice[J]. BMC Infect Dis,2019,19(1):792.
|
[22] RAVICHANDRAN G,NEUMANN K,BERKHOUT LK,et al. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice[J]. J Hepatol,2019,71(4):773-782.
|
[23] SHIMOJIMA Y,KISHIDA D,UENO KI,et al. Characteristics of circulating natural killer cells and their interferon-γproduction in active adult-onset still disease[J]. J Rheumatol,2019,46(10):1268-1276.
|